Meridian bioscience stock.

The Prime Meridian passes through Greenwich, England. The original Royal Observatory, today’s Flamsteed House, commemorates the establishment of the Prime Meridian with a museum and official denotations on the ground and, at night, in the s...

Meridian bioscience stock. Things To Know About Meridian bioscience stock.

22 nov. 2022 ... Analyze up to 10 years of full 10K Annual Reports and Quarterly 10Q SEC filings for Meridian Bioscience Inc (VIVO) using our online tools.Meridian Bioscience, Inc. is a life science company. The Company is engaged in the development, manufacture, sale and distribution of diagnostic testing systems and kits, primarily for certain gastrointestinal and respiratory infectious diseases, and elevated blood lead levels; and the manufacture and distribution of bulk antigens, antibodies, immunoassay blocking reagents, specialized ...Meridian Bioscience Inc. (VIVO) Company Bio. Meridian Biosciences is a fully integrated life science company that develops, manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and related products and offers biopharmaceutical enabling technologies. The company was founded in 1976 and is ...Jul 8, 2022 · Under the terms of the agreement, Meridian shareholders will receive $34.00 per share in cash, which represents a premium of approximately 32% over Meridian's closing stock price on the day before ...

EX-99.1 Exhibit 99.1 For Immediate Release MERIDIAN BIOSCIENCE REPORTS RECORD SETTING FIRST QUARTER FISCAL 2021 OPERATING RESULTS AND RAISES FULL YEAR FISCAL 2021 GUIDANCE CINCINNATI, OHIO February 5, 2021 (GLOBE NEWSWIRE) — Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial …Meridian Bioscience, Inc. is a life science company. The Company is engaged in the development, manufacture, sale and distribution of diagnostic testing systems and kits, primarily for certain gastrointestinal and respiratory infectious diseases, and elevated blood lead levels; and the manufacture and distribution of bulk antigens, antibodies, immunoassay blocking reagents, specialized ...

37.23M. MSFT. 378.61. +0.31%. 20.54M. View today's Meridian Bioscience Inc stock price and latest VIVO news and analysis. Create real-time notifications to follow any changes in the live stock price. Zacks Premium Feature View All Zacks #1 Ranked Stocks · Meridian Bioscience Inc. (VIVO) Quote Overview » Zacks Research » Meridian Bioscience Inc. (VIVO) ...

Jul 8, 2022 · South Korean billionaire Cho Young-sik’s SD Biosensor and Seoul-based private equity firm SJL Partners said they are acquiring Nasdaq-listed diagnostics company Meridian Bioscience for $1.53 ... Meridian Bioscience, Inc. is a life science company. The Company is engaged in the development, manufacture, sale and distribution of diagnostic testing systems and kits, primarily for certain gastrointestinal and respiratory infectious diseases, and elevated blood lead levels; and the manufacture and distribution of bulk antigens, antibodies, immunoassay blocking reagents, specialized ...About Meridian Bioscience, Inc. Meridian is a fully integrated life science company that develops, manufactures, markets and distributes a broad range of innovative diagnostic products.Find Salaries by Job Title at Meridian Bioscience. 31 Salaries (for 13 job titles) • Updated Oct 29, 2023. How much do Meridian Bioscience employees make? Glassdoor provides our best prediction for total pay in today's job market, along with other types of pay like cash bonuses, stock bonuses, profit sharing, sales commissions, and tips.Summary of all time highs, changes and price drops for Meridian Bioscience; Historical stock prices; Current Share Price: US$33.97: 52 Week High: US$34.38: 52 …

The illumipro-10™ is an automated isothermal amplification and detection system for use with Meridian Bioscience, Inc. ... All items in stock and available ...

Meridian’s stock soared 79% during that fiscal year. Newtown-based Meridian, founded in 1977, is Greater Cincinnati’s 16th-largest public company, …

Mr. Phillips VIVO stock SEC Form 4 insiders trading. David has made over 8 trades of the Meridian Bioscience stock since 2011, according to the Form 4 filled with the SEC. Most recently he exercised 7,500 units of VIVO stock worth $139,050 on 12 January 2022.. The largest trade he's ever made was buying 10,000 units of Meridian …Meridian Bioscience has 5 employees across 11 locations and $333.02 m in ... Meridian Bioscience. Stock Price. $34. 2023-01-30. Market Capitalization. $1.5 B.... Meridian Bioscience, Inc. Meridian is a fully ... Meridian's shares are traded on the NASDAQ Global Select Market, symbol VIVO.52 Week Low Date 03/24/23. Market Cap 3.46M. Shares Out 2.02M. 10 Day Average Volume 4,800. Dividend -. Dividend Yield -. Beta -. YTD % Change -7.23.Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you.

Nov 20, 2018 · Insiders trading at Meridian Bioscience. Over the last 21 years, insiders at Meridian Bioscience have traded over $8,089,514 worth of Meridian Bioscience stock and bought 228,244 units worth $3,053,655 . The most active insiders traders include Richard Eberly, John P. Kenny, and John A Kraeutler.On average, Meridian Bioscience …Mr. Anderson VIVO stock SEC Form 4 insiders trading. James has made over 3 trades of the Meridian Bioscience stock since 2011, according to the Form 4 filled with the SEC. Most recently he exercised 8,500 units of VIVO stock worth $173,230 on 6 January 2023.. The largest trade he's ever made was buying 10,000 units of Meridian …Medical Equipment Devices. Life Science Equipment. Meridian Bioscience, Inc. (VIVO) Avg Price Recovery. 5.0 Days. Best dividend capture stocks in Nov. Payout Ratio (FWD) 0.00%. Years of Dividend Increase.In an all-cash transaction valued at approximately $1.53bn, a consortium led by bio-diagnostic company SD Biosensor, Inc. and investment firm SJL Partners LLC is to acquire global provider of diagnostic testing solutions and life science raw materials Meridian Bioscience, Inc. Under the terms of the definitive merger agreement, Meridian ...Mr. McIlwraith VIVO stock SEC Form 4 insiders trading. John has made over 6 trades of the Meridian Bioscience stock since 2015, according to the Form 4 filled with the SEC. Most recently he bought 5,000 units of VIVO stock worth $37,950 on 25 February 2020.. The largest trade he's ever made was buying 5,000 units of Meridian Bioscience …Jul 8, 2022 · Under the terms of the agreement, Meridian shareholders will receive $34.00 per share in cash, which represents a premium of approximately 32% over Meridian's closing stock price on the day before ...

Get the latest stock quote, charts, news and analysis for Meridian Bioscience, Inc. (VIVO), a medical equipment company that develops diagnostic tests for various conditions. See …Meridian is an Ohio corporation and, therefore, governed by the corporate laws of Ohio. Since its stock is publicly traded on Nasdaq and it files reports with the Securities and Exchange Commission, it is also subject to NASD rules as well as various provisions of federal securities laws as recently changed by the Sarbanes-Oxley Act.

Jan 31, 2023 · The estimated Net Worth of John P. Kenny is at least $17.5 Million dollars as of 24 June 2022. Mr Kenny owns over 74,996 units of Meridian Bioscience stock worth over $11,093,515 and over the last 5 years he sold VIVO stock worth over $4,939,280. In addition, he makes $1,508,705 as Pres and CEO & Director at Meridian Bioscience.Jul 18, 2022 · Meridian Bioscience announced July 7 it's entered into a definitive merger agreement to be acquired by a pair of South Korean-based firms, SD Biosensor and SJL Partners, in a deal valued at $1.53 ... Newark, New Castle, USA, June 09, 2023 (GLOBE NEWSWIRE) -- The market analysis of the global chronic hepatitis B virus testing market was conducted by Growth Plus Reports in 2022 and valued at US$ 816.10 million. The market is expected to hit a revenue CAGR of 6.3% to reach US$ 1,498.24 million by 2031. Jun 8, 2023.VIVO stock is in the headlines as the company discloses a financial update. Meridian Bioscience ( VIVO) agreed to be acquired by SD Biosensor and SJL Partners in a $1.53 billion deal. Also, the ...Meridian Bioscience (VIVO) delivered earnings and revenue surprises of 33.33% and 2.63%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?On July 7, 2022, Meridian Bioscience, Inc. (“we,” “our,” “Meridian” or the “Company”), SD Biosensor, Inc., a corporation with limited liability organized under the laws of the Republic of Korea (“SDB”), Columbus Holding Company, a corporation organized under the laws of Delaware (“Columbus Holding”), and Madeira Acquisition Corp., a corporation organized under the laws ...Meridian’s stock soared 79% during that fiscal year. Newtown-based Meridian, founded in 1977, is Greater Cincinnati’s 16th-largest public company, according to Courier research. It reported ...Litigation Relating to the Merger. As previously disclosed, on July 7, 2022, Meridian Bioscience, Inc., a corporation organized under the laws of Ohio ("Meridian"), on the one hand, and SD Biosensor, Inc., a corporation with limited liability organized under the laws of the Republic of Korea, Columbus Holding Company, a corporation organized under the laws of Delaware ("Columbus Holding") and ...

Oct 10, 2017 · l28988ae10vk.htm MERIDIAN BIOSCIENCE, INC. 10-K. MERIDEIAN BIOSCIENCE, INC. 10-K. Washington, D.C. 20549. FOR ANNUAL AND TRANSITION REPORTS PURSUANT TO SECTIONS 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934. FOR THE FISCAL YEAR ENDED SEPTEMBER 30, 2007.

Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced that it has entered into a side letter with the buyer ...

CINCINNATI, Oct. 19, 2017 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced that based on preliminary results, it expe...Marco Calzavara VIVO stock SEC Form 4 insiders trading. Marco has made over 1 trades of the Meridian Bioscience stock since 2013, according to the Form 4 filled with the SEC. Most recently Marco sold 3,200 units of VIVO stock worth $69,792 on 30 May 2013.. The largest trade Marco's ever made was selling 3,200 units of Meridian …Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares. $0.Insiders trading at Meridian Bioscience. Over the last 21 years, insiders at Meridian Bioscience have traded over $8,089,514 worth of Meridian Bioscience stock and bought 228,244 units worth $3,053,655 . The most active insiders traders include Richard Eberly, John P. Kenny, and John A Kraeutler.On average, Meridian Bioscience …Meridian Bioscience (NASDAQ:VIVO) is a fully-integrated developer of diagnostic systems through its diagnostics segment, ... That means Meridian is a highly valued stock right now, and the prices ...Meridian Bioscience, Inc. is a life science company. The Company is engaged in the development, manufacture, sale and distribution of diagnostic testing systems and kits, primarily for certain gastrointestinal and respiratory infectious diseases, and elevated blood lead levels; and the manufacture and distribution of bulk antigens, antibodies, immunoassay blocking reagents, specialized ...The latest Meridian Bioscience stock prices, stock quotes, news, and VIVO history to help you invest and trade smarter. Meridian Bioscience has 5 employees across 11 locations and $333.02 m in annual revenue in FY 2022. See insights on Meridian Bioscience including office locations, competitors, ... Stock Price. $34. 2023-01-30. Market Capitalization. $1.5 B. 2023-01-30. Revenue. $333 M. FY, 2022.All series of Meridian Bioscience, Inc. options whose expiration dates are after 02-17-2023 will have their expiration dates advanced to 02-17-2023. Expiration dates occurring before 02-17-2023 (e.g., Flex options) will remain unchanged. All Meridian Bioscience, Inc. options will utilize a $.01 exercise threshold. Option Symbol: VIVOMeridian Bioscience gains after announcing Jan. 31 closing date for sale Seeking Alpha 355d Meridian Bioscience Announces Anticipated Closing Date of the Pending MergerCompany profile page for Meridian Bioscience Inc including stock price, company news, press releases, executives, board members, and contact information Meridian Bioscience Stock Hits New 52-Week High (VIVO) thestreet.com - March 26 at 5:22 PM Phoenix Union Bioscience High School usnews.com - March 23 at 3:29 PM Global "Diagnostics PCR Market" 2023: On-going Trends and Growth Insights by 2027 marketwatch.com - March 20 at 6:42 PM

Stock Price & Overview 4.57K followers VIVO is defunct since January 31, 2023. Acquired Summary All Comments Analysis Meridian Biosciences: Why I Moved On But May Go Back In Bram de Haas...Meridian Bioscience, Inc. is a life science company. The Company is engaged in the development, manufacture, sale and distribution of diagnostic testing systems and kits, primarily for certain gastrointestinal and respiratory infectious diseases, and elevated blood lead levels; and the manufacture and distribution of bulk antigens, antibodies, immunoassay blocking reagents, specialized ...Jan 31, 2023 · John has made over 6 trades of the Meridian Bioscience stock since 2015, according to the Form 4 filled with the SEC. Most recently he bought 5,000 units of VIVO stock worth $37,950 on 25 February 2020.Instagram:https://instagram. nvidia earnings expectationsemqq holdingsbest broker for algorithmic tradingstocks top gainers The standard meridian of India is 82.5 degrees east of the Greenwich Meridian. This meridian passes through the city of Allahabad. It runs through the center of the country. In 1905, this longitude was selected as the meridian to create the...Get the latest stock quote, charts, news and analysis for Meridian Bioscience, Inc. (VIVO), a medical equipment company that develops diagnostic tests for various conditions. See … new rmd rulesmake money exchanging currency Meridian Bioscience (VIVO) delivered earnings and revenue surprises of 33.33% and 2.63%, respectively, for the quarter ended September 2022. Do the numbers hold clues …Dec 1, 2023 · Susan D. Rolih is the Consultant at Meridian Bioscience. Markets; Tools Portfolios. Track performance, allocation, dividends, and risks. Search SEC filings. Annotate, download XLSX & look up similar tables. Stock screener. Filter, compare, and track stocks. Insiders trading. See how executives trade. Heat map. Visualize ... 2x leveraged etf Company profile page for Meridian Bioscience Inc including stock price, company news, press releases, executives, board members, and contact informationAbout Meridian. Meridian is a fully integrated life science company that develops, manufactures, markets, and distributes a broad range of innovative diagnostic and life science products. We are dedicated to developing and delivering better solutions that give answers with speed, accuracy, and simplicity that are redefining the possibilities of ...EX-99.1 Exhibit 99.1 For Immediate Release MERIDIAN BIOSCIENCE REPORTS RECORD SETTING FIRST QUARTER FISCAL 2021 OPERATING RESULTS AND RAISES FULL YEAR FISCAL 2021 GUIDANCE CINCINNATI, OHIO February 5, 2021 (GLOBE NEWSWIRE) — Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial …